FDA approves blood plasma treatment for COVID-19 patients

У вашего броузера проблема в совместимости с HTML5

The World Health Organization says that using plasma from COVID-19 survivors to treat those infected with the virus is still considered experimental therapy. It says that preliminary results are still inconclusive. But on Sunday, President Trump touted this type of treatment when he announced the FDA’s emergency authorization of using convalescent plasma to treat COVID-19. Media legend Larry King weighs in.

#QuestionMore #RTAmerica #InQuestion

Get exclusive content and watch full episodes now by downloading the Portable.TV app: http://download.rtamerica.tv/

Like us on Facebook http://www.facebook.com/RTAmerica
Follow us on Twitter http://twitter.com/RT_America